Alerta De Seguridad para SPOTCHEM II Basic PANEL-1 Reagent Test Strip and SPOTCHEM II Glucose Reagent Test Strip

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Arkray Factory Inc.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2016-01-29
  • Fecha de publicación del evento
    2016-01-29
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: arkray factory inc spotchem ii basic panel-1 reagent test strip and spotchem ii glucose reagent test strip the united states food and drug administration (fda) has issued an alert concerning the spotchem ii basic panel-1 reagent test strip and spotchem ii glucose reagent test strip [lot numbers: pn5c26 and ea4m78; manufacturing dates: november 2014 to september 2015; distribution dates: 18 february 2015 to 13 october 2015], manufactured by arkray factory inc. according to the fda, the manufacturer is recalling the spotchem ii basic panel-1 reagent test strip and spotchem ii glucose reagent test strip because they may report falsely low blood glucose levels when the true levels are above 265 mg/dl. there is a risk that the health care provider would not diagnose hyperglycemia (high blood sugar) including diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome in a timely manner and fail to treat elevated blood glucose levels. the issue may cause serious injury or death. the manufacturer sent an urgent medical device recall letter to customers in the united states beginning on 18 december 2015. the letter identified affected product, stated the reason for recall and provided instructions for returning unused product to the firm. tfor details, please refer to the fda websites: http://www.Accessdata.Fda.Gov/scripts/enforcement/enforce_rpt-event-detail.Cfm?action=detail&id=72867&w=01202016%e2%8c%a9=eng http://www.Fda.Gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm483792.Htm http://www.Fda.Gov/medicaldevices/safety/listofrecalls/ucm483760.Htm if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 29 january 2016.

Device

Manufacturer